Furthermore, we provide evidence that the lack of response in male mice is sex hormone-independent and that diet-induced obesity can blunt antitumor efficacy of combination treatment with the PPAR-γ antagonist and αPD-L1. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.